President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
50-Year Medalist StudyClinical Research
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

News Release

Joslin Diabetes Center President and CEO Ranch C. Kimball to Step Down

BOSTON – May 29, 2009 – Joslin Diabetes Center, the world’s preeminent diabetes research and clinical care organization, announced today that its President and CEO Ranch C. Kimball will step down by the end of August. Kimball has been widely credited with improving the overall health and fiscal stability of the world-renowned organization.

Appointed in February 2007, Kimball, who previously served as Secretary of Economic Development for the Commonwealth of Massachusetts, was charged with expanding philanthropic giving to the Joslin, completing the sale of a Joslin-owned real estate parcel, improving Joslin’s fiscal stability and raising Joslin’s visibility in the community. 

“The Board of Trustees and I are pleased that Ranch achieved our strategic goals which, when combined, have put Joslin on solid footing for our future,” said Kevin E. Conley, Chairman of the Board of Trustees. “Under Kimball’s leadership, philanthropic giving expanded dramatically with record giving in 2008, we completed the sale of a strategic real estate parcel, raising important revenue, Joslin’s financial position was solidified, and the Joslin’s visibility is significantly enhanced. We are extremely grateful to Ranch for his tremendous work to strengthen this vital institution.”

Kimball also led a strategic planning process to identify a long-term vision for the Joslin.  That process contributed to Kimball’s decision to step down.

“As part of our strategic planning process, it became clear that the next step for the Joslin is to further refine its scientific and medical agenda,” said Kimball.  “I believe those goals are best achieved by a leader with a different background and experience.  I am honored by the opportunity to have contributed to the important work of the Joslin.”

Kimball will work with the Board of Trustees through August to support a search for his successor. Trustees and colleagues praised Kimball for his management ability and his commitment to the Center’s health care mission.

“Ranch was exactly the President and CEO we needed at the time, and he set the stage for the next phase of the Joslin,” said John Brooks, Trustee and Finance Chair of the Center. “His willingness to work alongside the Board while we restructure leadership around our medical and scientific programs is welcome, and we will miss him.”

“Ranch did a great job understanding the clinical and scientific issues in diabetes.  We’d always see him walking through the halls in Clinic, asking doctors and nurses what was working, what wasn’t, and about patient care,” said Howard Wolpert, M.D., Director of the Insulin Pump program at Joslin and member of the Board of Trustees. “He brought a level of passion and commitment to our clinical care model for diabetes treatment.”

In addition to his service in the Romney administration, Kimball is one of Boston’s most respected and well-known leaders. He serves on the boards of the Mass Business Roundtable, and Boston World Partnerships.  He is Chair of the Board of Overseers of the Museum of Science, and Vice Chair of the Board of MassPort, where he also chairs the audit and finance committees.  He was previously managing partner of private equity firm Kissinger McLarty Capital Group, and a long-time partner at Boston Consulting Group.